ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

RFA Available: Chemoprevention Trials

August 5, 1994

In Brief: Sundwall Leaves Hatch to head HRSA; Terry Joins Damon Biotech; Irlin On Hunger Strike

September 12, 1986

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013